Perillyl alcohol

Generic Name
Perillyl alcohol
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C10H16O
CAS Number
18457-55-1
Unique Ingredient Identifier
3UL4QIY642
Background

Perillyl alcohol is under investigation in clinical trial NCT02704858 (Safety and Efficacy Study in Recurrent Grade IV Glioma).

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

Phase 1
Recruiting
Conditions
Glioblastoma Multiforme
Interventions
Drug: Perillyl alcohol
First Posted Date
2016-03-10
Last Posted Date
2024-12-09
Lead Sponsor
Neonc Technologies, Inc.
Target Recruit Count
49
Registration Number
NCT02704858
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Northwell Health, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

Atlantic Health (Overlook Medical Center), Summit, New Jersey, United States

and more 5 locations

Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses

Phase 2
Completed
Conditions
Precancerous Condition
Interventions
Other: placebo
Drug: perillyl alcohol
First Posted Date
2008-02-06
Last Posted Date
2015-04-01
Lead Sponsor
University of Arizona
Target Recruit Count
89
Registration Number
NCT00608634
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2
Completed
Conditions
Prostate Cancer
First Posted Date
2004-07-21
Last Posted Date
2019-12-13
Lead Sponsor
University of Wisconsin, Madison
Registration Number
NCT00003238
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Leonard C. Ferguson Cancer Center, Freeport, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

๐Ÿ‡บ๐Ÿ‡ธ

Green Bay Oncology, Ltd., Green Bay, Wisconsin, United States

and more 5 locations

Perillyl Alcohol in Treating Patients With Refractory Cancer

First Posted Date
2004-07-19
Last Posted Date
2013-02-11
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
25
Registration Number
NCT00002862
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Yale Comprehensive Cancer Center, New Haven, Connecticut, United States

Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2004-07-19
Last Posted Date
2019-12-13
Lead Sponsor
University of Wisconsin, Madison
Registration Number
NCT00003219
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States

Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
First Posted Date
2004-03-31
Last Posted Date
2014-09-10
Lead Sponsor
Indiana University School of Medicine
Registration Number
NCT00003769
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Indiana University Cancer Center, Indianapolis, Indiana, United States

Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy

Phase 1
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-12-18
Lead Sponsor
The Cleveland Clinic
Registration Number
NCT00022425
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy